Innoviva (INVA) Revenue (2011 - 2026)
Innoviva (INVA) reported Revenue of $119.59 million for Q2 2026, up 19.3% from $100.28 million a year earlier and up 22.0% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Revenue (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Innoviva's Revenue came in at $440 million, up 18.8% year-over-year; for FY2025, it was $411.33 million, up 14.7% from FY2024.
- Revenue has a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
- By year, Revenue came in at $358.71 million in FY2024 (+15.5%), $310.46 million in FY2023 (-6.3%), $331.34 million in FY2022 (-15.4%) and $391.87 million in FY2021 (+16.4%).
- The Q2 2026 figure ranks as the highest quarterly Revenue since Q1 2012.
- Year over year, Revenue has now increased in each of the last six quarters, with growth averaging 15.0% over the last six quarters.
- The high point for year-over-year Revenue in five years was Q4 2025 (growth of 24.8%); the low point was Q2 2023 (a decline of 25.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $97.99 million (Q1 2026), $114.61 million (Q4 2025) and $107.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Innoviva | 1.53 Bn | -757.39 Mn | 90.62 Mn | 119.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 119.59 Mn |
| Mar 31, 2026 | 97.99 Mn |
| Dec 31, 2025 | 114.61 Mn |
| Sep 30, 2025 | 107.80 Mn |
| Jun 30, 2025 | 100.28 Mn |
| Mar 31, 2025 | 88.63 Mn |
| Dec 31, 2024 | 91.81 Mn |
| Sep 30, 2024 | 89.51 Mn |
| Jun 30, 2024 | 99.90 Mn |
| Mar 31, 2024 | 77.50 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Jun 30, 2023 | 80.99 Mn |
| Mar 31, 2023 | 76.37 Mn |
| Sep 30, 2022 | 67.26 Mn |
| Jun 30, 2022 | 108.22 Mn |
| Mar 31, 2022 | 90.06 Mn |
| Dec 31, 2021 | 107.68 Mn |
| Sep 30, 2021 | 97.86 Mn |
| Jun 30, 2021 | 100.81 Mn |
| Mar 31, 2021 | 85.52 Mn |
API Access
Innoviva Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();